Gay men weigh consequences before divulging HIV status

November 21, 2001

COLUMBUS, Ohio - Before confiding to friends and family that they are HIV-positive, men infected with the virus tend to weigh the consequences of that disclosure.

This flies in the face of the theory that disease progression - how quickly serious symptoms appear - determines when a person discloses his or her disease, said Julie Serovich, an associate professor of human development and family science and director of the Marriage and Family Clinic at Ohio State University. HIV is the virus that causes AIDS.

A report on her research appears in a recent issue of the journal AIDS Education and Prevention.

"Men tend to weigh the benefits and drawbacks of revealing that they have HIV," she said. "Although we only looked at men in this study, we found in a related study that women have a tendency to base their decision to disclose more on their need for social support. This suggests that women may consider different consequences than do men."

Of the 138 HIV-positive gay men in the study, just over half (55 percent) disclosed their disease status to family, while 63 percent told friends. Serovich also found that three out of four men had told their partners.

Disclosure is pivotal in reducing the behaviors that continue the spread of the disease, she said. Most of the men in the study said they had contracted HIV via unsafe sexual practices.

For the men in this study, the top three reasons for disclosing included wanting to keep friends and family safe from HIV; seeking understanding; and feeling that others have a right to know. The top three reasons for keeping HIV status under wraps were avoiding fights, being lectured and being blamed.

The men in the study were interviewed and asked to fill out surveys about their decision to disclose or not to disclose, and to whom.

"If the positive consequences outweighed the negative repercussions, chances were good that a man told friends and family," Serovich said. "But the same doesn't seem to hold true for sexual partners, and we're not sure why.

"The consequences with sexual partners are very different than the consequences with family and friends, so we may not have tapped them in this study," she said. "Individuals with a sexual partner may worry more about whether or not they'll still have a relationship or if they'll be abandoned if they do disclose."

Serovich dispelled the theory that the progression of serious symptoms common to HIV convinces an infected man to disclose.

"When the HIV/AIDS epidemic was in its infancy, the progression of the disease was certain," she said. "A person contracted HIV, which quickly developed into AIDS, and the person usually died. The disease had obvious physical manifestations, such as lesions and extreme weight loss. Hiding the disease was difficult. But advancements in HIV therapies now keep the virus under control in many cases."

Disclosure often has substantial consequences - the infected person may feel threatened when people know. On the other hand, disclosure might mean he would get needed emotional, physical and social support.

"In this study, we were looking to identify the 'right' people to tell," Serovich said. "No one should walk around with a billboard on their back saying 'I'm HIV-positive' unless there's something to be gained."

The research was supported by grants from the National Institutes of Mental Health and the National Institute of Allergy and Infectious Diseases.
-end-
Contact: Julie Serovich, 614-292-5685; Serovich.1@osu.edu
Written by Holly Wagner, 614-292-8310; Wagner.235@osu.edu

Ohio State University

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.